WESEARCH
Live / Allowed — Second extension granted (statement of use) (as of 24 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98773552
- Mark type
- Word mark
- Filed
- 27 Sept 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of the importance of testing for chronic kidney disease and for changes to screening guidelines and policies
- Class 044 — Medical, beauty and agricultural services: Providing health information on chronic kidney disease
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 2 GRANTED
- 24 Jun 2026 — SOU EXTENSION 2 FILED
- 24 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 1 GRANTED
- 01 Oct 2025 — SOU EXTENSION 1 FILED
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE